Results 121 to 130 of about 6,242,042 (194)

Glycogen storage disease type IX: Long-term follow-up of 52 patients from three European countries. [PDF]

open access: yesMol Genet Metab Rep
Magner M   +17 more
europepmc   +1 more source

Noninfectious endocarditis as a novel cardiac manifestation of glycogen storage disease type IV: a case report. [PDF]

open access: yesTransl Pediatr
Kingdon T   +5 more
europepmc   +1 more source

Clinical and molecular characterization of hepatic glycogen storage disease in Saudi Arabia. [PDF]

open access: yesPLoS One
Al-Hussaini A   +14 more
europepmc   +1 more source

Liver-directed AAV gene therapy in mice corrects glycogen storage disease type IX γ2. [PDF]

open access: yesSci Adv
Gibson RA   +9 more
europepmc   +1 more source

Hepatocyte-specific Cas9-mediated editing of G6pc and Slc37a4 elicits comparable biochemical and regulatory responses between glycogen storage disease (GSD) type Ia and Ib mice. [PDF]

open access: yesMol Metab
Krishnamurthy KA   +17 more
europepmc   +1 more source

Efficacious genome editing in infant mice with glycogen storage disease type Ia. [PDF]

open access: yesJCI Insight
Arnson B   +13 more
europepmc   +1 more source

Unifying the Communities of Early-Onset Glycogen Storage Disease Type IV and Adult Polyglucosan Body Disease Through a Genetic Prevalence Study of <i>GBE1</i>-Related Disease. [PDF]

open access: yesJIMD Rep
Koch RL   +13 more
europepmc   +1 more source

Empagliflozin as treatment in glycogen storage disease type IB patients. [PDF]

open access: yesMol Genet Metab Rep
Arbelo Rodríguez M   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy